UICC Study Group on Basic and Clinical Cancer Research: angiogenesis revisited.
Burger
M M
MM
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D010447:Peptide Hydrolases / Q000378:metabolism; D015398:Signal Transduction
D020533:Angiogenesis Inhibitors; D010447:Peptide Hydrolases